A detailed history of Global Trust Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 500 shares of CRSP stock, worth $23,940. This represents 0.01% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$23,940
Previous $27,000 14.81%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$51.17 - $68.18 $15,351 - $20,454
300 Added 150.0%
500 $27,000
Q1 2024

Apr 12, 2024

BUY
$60.67 - $89.12 $12,134 - $17,824
200 New
200 $13,000

Others Institutions Holding CRSP

About CRISPR Therapeutics AG


  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.74B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Global Trust Asset Management, LLC Portfolio

Follow Global Trust Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Trust Asset Management, LLC with notifications on news.